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Abstract
Introduction: Many approaches have been examined to try to predict patient outcome after cardiopulmonary 
resuscitation. It has been shown that plasma DNA could predict mortality in critically ill patients but no data are 
available regarding its clinical value in patients after out-of-hospital cardiac arrest. In this study we investigated 
whether plasma DNA on arrival at the emergency room may be useful in predicting the outcome of these patients.
Methods: We performed a prospective study of out-of-hospital patients with cardiac arrest who achieved return of 
spontaneous circulation after successful resuscitation. Cardiovascular co-morbidities and resuscitation history were 
recorded according to the Utstein Style. The outcome measures were 24 h and overall in-hospital mortality. Cell-free 
plasma DNA was measured by real-time quantitative PCR assay for the β-globin gene in blood samples drawn within 
two hours after the arrest. Descriptive statistics, multiple logistic regression analysis, and receiver operator characteristic 
(ROC) curves were calculated.
Results: Eighty-five consecutive patients were analyzed with a median time to return of spontaneous circulation of 27 
minutes (interquartile range (IQR) 18 to 35). Thirty patients died within 24 h and 58 died during the hospital course. 
Plasma DNA concentrations at admission were higher in non-survivors at 24 h than in survivors (median 5,520 genome 
equivalents (GE)/ml, vs 2810 GE/ml, P < 0.01), and were also higher in patients who died in the hospital than in survivors 
to discharge (median 4,150 GE/ml vs 2,460 GE/ml, P < 0.01). Lactate clearance at six hours was significantly higher in 24 
h survivors (P < 0.05). The area under the ROC curves for plasma DNA to predict 24-hour mortality and in-hospital 
mortality were 0.796 (95% confidence interval (CI) 0.701 to 0.890) and 0.652 (95% CI 0.533 to 0.770). The best cut-off 
value of plasma DNA for 24-h mortality was 4,340 GE/ml (sensitivity 76%, specificity 83%), and for in-hospital mortality 
was 3,485 GE/ml (sensitivity 63%, specificity 69%). Multiple logistic regression analysis showed that the risk of 24-h and 
of in-hospital mortality increased 1.75-fold and 1.36-fold respectively, for every 500 GE/ml increase in plasma DNA.
Conclusions: Plasma DNA levels may be a useful biomarker in predicting outcome after out-of hospital cardiac arrest.
Introduction
Overall survival rate from out-of-hospital cardiac arrest has 
not increased in parallel with the improvements in cardio-
pulmonary resuscitation (CPR) [1,2]. The hospital dis-
charge rate is 15% in a meta-analysis that included a total 
population of over 26,000 patients [3]. Pre-morbid factors, 
peri-arrest and post-arrest variables [4,5], and several serum 
markers, for example, two neuroproteins, neuro-specific 
enolase and S-100 [6,7], serum lactate [8,9], and B-type 
natriuretic peptide [10,11] have been examined to predict 
outcome after CPR, although none have proved entirely 
useful.
The majority of patients who achieve return of spontaneous 
circulation after successful CPR have a high risk to death in 
the post-arrest period. A few clinical studies have shown 
elevated plasma concentrations of soluble adhesion mole-
cules (selectins) [12] and cytokines [13,14] in patients 
resuscitated from cardiac arrest. This immediate post-resus-
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citation period has some similarities to the sepsis syndrome 
and septic shock in terms of the inflammatory cascade acti-
vation and microcirculatory hypoperfusion [15]. As 
increased concentrations of cell-free DNA have been found 
in patients with sepsis and septic shock [16-18], and the 
plasma DNA concentration is an independent predictor for 
ICU mortality in these patients [19], we hypothesized that 
admission DNA concentrations may also predict mortality 
in patients in the post-cardiac arrest resuscitation period. 
Therefore, the aim of this study was to evaluate whether 
cell-free plasma DNA on admission is associated with 




Between January 2005 and June 2007, 113 consecutive 
adult patients who presented to the emergency room after 
non-traumatic, normothermic, out-of-hospital cardiac arrest 
were recruited into the study. The inclusion criteria were: 1) 
age more than 17 years, 2) cardiac arrest prior to the arrival 
of emergency personnel, 3) pre-arrest GCS = 15 or indepen-
dent ADLs, 4) no written do not attempt resuscitation 
(DNAR) order. Exclusion criteria were: 1) successful resus-
citation by bystanders prior to arrival of pre-hospital pro-
viders, 2) interval between collapse and the start of CPR 
longer than 15 minutes, 3) no return of spontaneous circula-
tion could be achieved within 60 minutes, 4) survival for 
less than 12 hours after the event, 5) chronic renal failure 
treated by hemodialysis, neoplastic diseases, stroke or acute 
coronary syndrome in the previous 30 days, 6) the emer-
gency physician was unable to diagnose their disease, and 
7) their families refused to provide informed consent to par-
ticipate. The study was approved by the local ethics com-
mittee. Patient data were collected according to the Utstein 
Style [20,21] in which cardiac arrest is defined as the 
absence of palpable pulse and effective spontaneous respi-
ration with initial rhythm ventricular fibrillation (VF), 
pulseless ventricular tachycardia (PVT), pulseless electrical 
activity (PEA) and asystole. Resuscitation protocols fol-
lowed the European Resuscitation Council guidelines [22] 
and the American Heart Association guidelines [23,24]. 
Therapeutic hypothermia (33°C as the target temperature 
for 24 h) was subsequently performed in comatose survi-
vors whose systolic blood pressure had increased to above 
90 mm Hg [25,26]. The primary endpoint in the study was 
24-h mortality. Secondary endpoint was in-hospital mortal-
ity.
Blood sampling, processing of plasma and DNA extraction
After return of spontaneous circulation with standard 
advanced cardiovascular life support according to the Euro-
pean Resuscitation Council guidelines [22] and the Ameri-
can Heart Association guidelines [23,24], a 10 ml blood 
sample to measure cell-free plasma DNA was taken from 
the antecubital vein of each patient immediately after return 
of spontaneous circulation in the emergency room. Plasma 
and cells were separated by centrifugation at 1,600 g 
(+4°C) for 10 minutes and plasma samples were stored at -
80°C. Plasma samples were centrifuged at 16,000 g for 10 
minutes before DNA extraction to remove any residual 
cells. DNA was extracted from 200-μl plasma samples 
using the QIAamp DNA Blood Mini Kit (QIAGEN, 
Hilden, Germany) according to the blood and body fluid 
protocol recommended by the manufacturer.
Real-time quantitative PCR
Plasma DNA was measured in duplicate samples by real-
time quantitative PCR assay for the β-globin gene [27] 
using the ABI PRISM 7000 sequence detection system 
(Applied Biosystems Inc, Foster City,, CA 94404, USA). 
PCR primers and the fluorescent probe were designed by 
Primer Express software (Applied Biosystems). The primer 
and probe sequences were as follows: forward primer 5'-
GCA CCT GAC TCC TGA GGA GAA-3', reverse primer 
5'-CAC CAA CTT CAT CCA CGT TCA-3', and a single-
labeled fluorescent MGB-probe 5'-FAM-TCT GCC GTT 
ACT GCC CT-MGB-NFQ, where MGB is a minor groove 
binding molecule and NFQ a non-fluorescent quencher 
molecule. Samples were analyzed in duplicate in a reaction 
volume of 25 μl containing 5 μl of sample, 300 nM of each 
primer, 200 nM of probe and 1×Taqman master mix 
(Applied Biosystems). PCR cycling conditions were two 
minutes at +50°C, 10 minutes at +95°C, and 46 cycles of 20 
seconds at +95°C and one minute at +60°C. We used a 10-
fold serial dilution of human genomic DNA (QIAGEN, 
Hilden, Germany) as a standard curve. The imprecision of 
this system has been reported previously (20), with a CV 
for the threshold cycle of 1.1%. Raw data are converted into 
units of copies of genomes, and expressed as genome 
equivalents (GE), per ml plasma (1 GE = 6.6 pg DNA). 
DNA levels are given to the nearest 25 genome-equivalents 
(GE)/ml and the detection limit is 12.5 GE/ml.
Statistics
Continuous data are presented as the median and inter-
quartile range. Discrete variables are given as counts and 
percentages. Lactate clearance at six hours was defined as 
the difference in initial lactate concentration on arrival at 
the ED to six hours afterwards divided by initial lactate 
concentration value and multiplied by 100. Univariate com-
parisons of continuous data were performed by Mann-
Whitney U-test, and by Chi-square for categorical vari-
ables. Non-normal distributions were transformed into nor-
mal distributions using a logarithmic transformation. The 
confidence interval (95% CI) was determined as an indica-
tion of the precision of an estimate of a population value. 
The odds ratio (OR) was calculated as an estimate of rela-Arnalich et al. Critical Care 2010, 14:R47
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tive risk between two groups on the basis of the mortality as 
outcome. Multiple logistic regression analysis was used to 
determine the independent contribution of multiple vari-
ables to the outcome of 24-h and in-hospital mortality, and 
for calculation of adjusted odds ratio. We selected candidate 
variables for the regression model that were shown to 
impact mortality in prior studies [1,2,26]. A P < 0.01 level 
was used for the inclusion of the variables in the model. 
The discriminative power of DNA and lactate clearance to 
predict mortality was determined with the use of receiver 
operator characteristic (ROC) curves. We calculated areas 
under the curve (AUCs) with 95% CIs, the best predictive 
cut-off values and positive likelihood ratios with 95% CIs 
according to standard procedures. Statistical significance 
was set at P < 0.05 in all tests. The statistical analyses were 
computed with SPSS 12.0 statistical software (SPSS, Chi-
cago, Ill., USA).
Results
Overall, 85 patients matched the inclusion criteria for this 
study. The cause of cardiac arrest was: underlying cardiac 
disorder (n = 46), respiratory failure (n = 30), metabolic 
factors (n = 6) and hypovolemia (n = 3). Twenty-four-hour 
mortality and in-hospital mortality were 35.2% and 65.8%, 
respectively (Table 1). Patient demography and medical 
history prior to cardiac arrest, the initial ECG-pattern, and 
the clinical findings at the time of admission to the emer-
gency room are described in Table 1. Acute myocardial 
infarction (AMI) was determined as the final diagnosis and 
cause of cardiac arrest in 48 patients (56.5%), 35 patients 
(72.9%) had coronary angiography and 25 (52.1%) 
received percutaneous coronary intervention with stent 
placement. The main artery occluded was the left anterior 
descending in 14 patients, the right coronary artery in eight 
and the circumflex in seven. Four patients had more than 
one artery involved. Eighteen patients were treated with 
mild therapeutic hypothermia according to the ALS Task 
Force of the International Liaison Committee on Resuscita-
tion (25). Initial cold fluid infusions and ice packs com-
bined with external cooling with cold blankets was used to 
achieve a core temperature of 33°C (time to achievement 
5.3 h ± 2.1 h) and maintained for 24 hours.
The median duration of the ICU stay was 12 days (IQR 5 to 
21), and the median time until hospital discharge was 36 
days (IQR 19 to 47). Clinical characteristics of 24-hour sur-
vivors and non-survivors are listed in Table 2. Except for 
the presence of diabetes, there was no statistical difference 
with respect to other cardiovascular risk factors or comor-
bidities. The median cell-free plasma DNA concentration at 
admission was higher in non-survivors at 24 hours than in 
survivors (5,520 GE/ml, vs 2,810 GE/ml, P < 0.01). The 
plasma DNA concentration was higher in patients with 
CPR duration longer than 30 minutes than in patients with 
shorter time of resuscitation (4,470 GE/ml, vs 3,150 GE/ml, 
P < 0.05). In addition to plasma DNA, bystander basic life 
support, total downtime interval (time from collapse until 
return of spontaneous circulation), asystole as the present-
ing cardiac rhythm, ongoing CPR on arrival at the emer-
gency room, palpable pulse on arrival at the emergency 
room, six-hour lactate concentration, six-hour lactate clear-
ance, serum glucose and urea concentrations, and con-
firmed AMI as final diagnosis were also found to be 
predictive of 24-hour mortality in a univariate analysis 
(Table 2). The plasma DNA level at admission was signifi-
cantly correlated with the total downtime (r = 0.579, P < 
0.001), maximum lactate concentration (r = 0.602, P < 
0.001), and the first 24-hour APACHE II score (r = 0.415, P 
< 0.003). Plasma DNA concentration did not correlate with 
urea concentration (r = 0.26, P = 0.053), nor was it in corre-
lation with age, leukocyte count, troponin, creatinine or 
glucose.
Plasma DNA concentrations at admission also showed sta-
tistical significance regarding the secondary endpoint of in-
hospital mortality (Table 3). Plasma DNA concentrations 
were higher in hospital non-survivors than in survivors to 
discharge (median 4,150 GE/ml vs 2,430 GE/ml, P < 0.01). 
Asystole as the presenting cardiac rhythm and confirmed 
AMI as final diagnosis were also found to be statistically 
significant.
A multivariate analysis by logistic regression to identify 
factors having independent predictive value for 24-hour 
mortality and in-hospital mortality was performed. The fol-
lowing variables were entered: 1) age; 2) sex; 3) diabetes 
mellitus; 4) hypertension; 5) coronary artery disease; 6) 
chronic heart failure; 7) COPD/emphysema; 8) witnessed 
cardiac arrest; 9) bystander initiated CPR; 10) total down-
time interval; 11) asystole as the presenting cardiac rhythm; 
12) unconsciousness on arrival at the ER; 13) coma Glas-
gow scale < 6 on arrival at the ER; 14) ongoing CPR on 
arrival at the ER; 15) palpable pulse on arrival at the ER; 
15) supraventricular rhythm in the ER; 16) defibrillation in 
the ER; 17) adrenaline in the ER; 18) cardiogenic shock; 
19) confirmed acute myocardial infarction as final diagno-
sis. Plasma DNA concentrations was the only independent 
predictor of 24-hour mortality and in-hospital mortality, 
whereas all other variables were no independently associ-
ated with the outcome (Table 4).
ROC curves were calculated for the use of plasma DNA as 
a predictor of 24-hour and in-hospital mortality and for lac-
tate clearance to predict 24-hour mortality. The area under 
the ROC curves for plasma DNA to predict 24-hour mortal-
ity and in-hospital mortality were 0.796 (95% CI 0.701 to 
0.890) and 0.652 (95% CI 0.533 to 0.770) (Figure 1). The 
area under the ROC curve for six-hour lactate concentration 
to predict 24-hour mortality was 0.576 (95% CI, 0.450 to 
0.701) (Figure 2). The best cut-off value of plasma DNA at 
admission for 24-hour mortality was 4,340 GE/ml with a 
sensitivity of 76%, specificity of 83%, positive likelihood Arnalich et al. Critical Care 2010, 14:R47
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Table 1: Descriptive characteristics of the study cohort
Age, years 62 (51 to 69)
Female 38 (44.7)
Cause of cardiac arrest Underlying cardiac disorder 48 (56.5)
Respiratory failure 28 (32.9)
Metabolic factors 7 (8.2)
Hypovolemia 2 (2.4)




Coronary artery disease 29 (34.1)
Chronic heart failure 27 (31.7)
COPD/emphysema 24 (28.2)
Initial cardiac rhythm Ventricular fibrilation 19 (22.4)
Pulseles electrical activity 21 (24.7)
Asystole 45 (52.9)
Resuscitation factors "no flow" time 3 (2 to 6)
"low flow" time 24 (18 to 34)
Witnessed arrest, n (%) 47 (55.2)
Bystander CPR, n (%) 25 (29,4)
Ongoing CPR 21 (24.7)
Glasgow Coma Scale 6 (4 to 8)
Defibrillation 40 (47.1)
Intravenous adrenaline 67 (78.8)Arnalich et al. Critical Care 2010, 14:R47
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ratio of 2.41 (95% CI, 2.04 to 3.26) and correct classifica-
tion rate of 73%. Regarding the secondary endpoint of in-
hospital mortality, the best cut-off value of plasma DNA 
was 3,485 GE/ml with a sensitivity of 63%, specificity of 
69%, positive likelihood ratio of 1.75 (95% CI, 1.44 to 
2.35) and correct classification rate of 62%. The best cutoff 
value of six-hour lactate in predicting 24-hour mortality 
was 7.1 mmol/l, with a sensitivity of 64%, specificity of 
61%, positive likelihood ratio of 1.32 (95% CI, 1.10 to 
1.84) and correct classification rate of 57%.
Discussion
A predictive test that would be applicable to comatose 
patients in the emergency department early after CPR is 
Adrenaline dose (mg) 4 (2 to 5)
In-hospital diagnosis and treatment Head CT 82 (96.4)
Thorax CT 37 (43.5)
Mild therapeutic hypothermia 18 (21.2)
Cardiogenic shock 16 (18.8)
Acute myocardial infarction 48 (56.5)
Coronary angiography 35 (72.9% of the AMI)
Percutaneous coronary intervention 25 (52.1% of the AMI)
Intra-aortic balloon pump 6 (7.1)
Clinical outcome 24-h mortality 30 (35.2)
In-hospital mortality 56 (65.8)
Laboratory values pH 7.14 (7.08 to 7.20)
Basal lactate (mmol/l) 9.6 (7.0 to 12.7)
6-h lactate (mmol/l) 6.7 (4.8 to 8.0)
6-h lactate clearance (%) 45 (32 to 58)
Bicarbonate (mmol/l) 12.8 (10.3 to 17.8)
Glucose (mg/dl) 210 (175 to 240)
Blood urea nitrogen (mg/dl) 38 (28 to 52)
Creatinine (mg/dl) 1.5 (1.1 to 1.8)
Troponin I (ng/dl) 1.0 (0.5 to 1.4)
Data are median (IQR) or number (%). CT, computed tomography.
Table 1: Descriptive characteristics of the study cohort (Continued)Arnalich et al. Critical Care 2010, 14:R47
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Age, years 60 (51 to 69) 62 (52 to 70) NS
Female, 25 (45.4) 13 (43.3) NS
Hypertension 30 (54.5) 18 (60.0) NS
Diabetes 16 (29.1) 14 (46.6) <0.05
Coronary artery disease 18 (32.7) 11 (36.6) NS
Chronic Heart Failure 16 (29.1) 11 (36.6) NS
Witnessed arrest 31 (56.4) 16 (53.3) NS
Bystander CPR 20 (36.4) 5 (16.6) <0.01
Total downtime 22 (15 to 29) 31 ((22 to 38) 0,002
CGS <6 on arrival at the ER 47 (85.5) 27 (90.0) NS
Ongoing CPR on arrival at the ER 16 (29.1) 5 (16.7) <0.05
Palpable pulse on arrival at the ER 45 (90.9) 19 (70.0) <0.01
Supraventricular rhythm in the ER 34 (61.8) 20 (66.7) NS
Asystole 23 (41.8) 22 (73.3) 0.002
Defibrillation in the ER 27 (49.1) 13 (43.3) NS
Adrenaline in the ER 41 (74.5) 26 (86.7) NS
Cardiogenic shock 9 (16.4) 7 (23.3) NS
Confirmed AMI as final diagnosis 34 (61.8) 14 (46.7) <0.05
APACHE II score 35 (32 to 38) 38 (33 to 41) NS
Plasma DNA (GE/ml) 3,970 (2,460 to 4,980) 5,520 (3,870 to 6,400) 0.001
Basal lactate (mmol/l) 10.7 (9.6 to 12.2) 11.9 (10.7 to 13.4) NS
6-h lactate (mmol/l) 5.7 (4.9 to 6.6) 8.4 (7.1 to 10.2) <0.01
6-h lactate clearance (%) 55 (47 to 65) 38 (16 to 57) <0.05Arnalich et al. Critical Care 2010, 14:R47
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needed to help optimize the resuscitative efforts. This is the 
first prospective clinical study to evaluate the prognostic 
value of plasma DNA concentration on arrival at the emer-
gency room in patients with out-of-hospital cardiac arrests. 
Our study shows that high plasma DNA concentration is 
associated with both 24-hour and in-hospital mortality. A 
multiple logistic regression analysis showed that raised 
plasma DNA level was a strong independent predictor of 
24-hour mortality and was also independently associated 
with overall hospital mortality.
The post-resuscitation period after cardiac arrest has been 
compared to a sepsis-like syndrome, with components of 
circulatory, cardiogenic, and distributive shock [15]. It has 
been shown that plasma DNA is a useful independent pre-
dictor of mortality and sepsis in intensive care patients 
[16,17]. A prognostic value has also been found in emer-
gency department patients with sepsis [18]. Cell-free 
plasma DNA measured on admission to the intensive care 
unit was found to be a predictor of outcome in severe sepsis 
and septic shock patients included in the Finnsepsis Study 
Group [19]. As current evidence suggests that the 
pathophysiology of post-cardiac arrest shock is very similar 
to that of patients with septic shock, we hypothesized that 
DNA concentrations at hospital admission might also pre-
dict mortality in patients in the immediate post-arrest 
period. The mechanisms underlying this period probably 
involve a whole-body ischemia and reperfusion instability 
that triggers the inflammatory cascade activation similar to 
that seen in severe sepsis. Plasma DNA is likely to be 
released from damaged and inflamed tissues, and in this 
context it might act as a marker of early outcome of patients 
with hypoxic-ischemic encephalopathy after cardiac arrest. 
We have demonstrated a role for plasma DNA as an early 
predictor of mortality in patients after cardiac arrest. Thus, 
the ability for rapid risk stratification of survival may allow 
clinicians to make more rational therapeutic decisions.
Moderate increases in plasma in plasma DNA may be asso-
ciated with the chronic inflammatory response to athero-
sclerotic process which often occurs in elderly patients 
[28]. In our study there was no difference with respect to 
cardiovascular risk factors or chronic comorbidities except 
for diabetes within survivors and non-survivors patients and 
when entered into the logistic regression model for hospital 
mortality the adjusted odds ratio was not significant. There-
fore it is likely that differences in plasma DNA levels in our 
study reflect the acute event of cardiac arrest rather than 
chronic illness.
Tissue hypo-perfusion during the early phase of post-car-
diac arrest induces an increase in serum lactate because of 
anaerobic glycolisis. We have found that cell-free plasma 
DNA concentration at inclusion correlated significantly 
with initial lactate concentrations and maximum lactate 
concentrations within a 24-hour period, which may reflect 
the effect of tissue hypoxia on apoptotic or necrotic cell 
death. Effective lactate clearance which likely reflects 
improved tissue perfusion is associated with decreased 
mortality in severe sepsis and other critical-care patient 
populations [29,30]. Two studies have reported that post-
cardiac arrest patients with more effective lactate clearance 
had improved survival [7,8]. Similarly, the current study 
revealed that lactate clearance at six hours was significantly 
higher in survivors compared to non-survivors at 24 hours, 
but we did not find this variable to be an independent pre-
dictor for early or late mortality when entered into the mul-
tivariable analysis. Further studies are required to establish 
the independent predictive value of effective lactate clear-
ance after cardiac arrest.
An increase in plasma DNA concentration in critically ill 
patients may be also due to a decrease in clearance effi-
ciency. The clearance mechanism of DNA from the circula-
tion is poorly understood [31]. In mice, nucleotides are 
mainly cleared by liver [32]. Approximately 0.5 to 2% of 
circulating plasma DNA crosses the kidney barrier and is 
excreted into urine [33]. We found that serum urea or creati-
nine were not independently associated with plasma DNA 
concentrations, which is consistent with data from experi-
mental studies. However, further investigations are required 
to understand the dynamics of plasma DNA removal in 
patients with impaired renal and hepatic function.
The current study has several methodological limitations. 
First, it is a single centre study for CPR after out-of-hospital 
cardiac arrest. Second, the majority of patients had unfavor-
able peri-arrest variables such as long downtime intervals 
and pulseless electric activity as presenting arrest rhythms. 
Blood sugar (mg/dl) 214 (180 to 234) 255 (210 to 275) <0.05
Blood urea nitrogen (mg/dl) 35 (28 to 41) 46 (33 to 54) <0.05
Data are median (IQR) or number (%). CPR, cardiopulmonary resuscitation; CGS, coma Glasgow scale; ER, emergency room; AMI, acute 
myocardial infarction.
Table 2: Univariate analysis: comparisons of factors associated with 24-h mortality (Continued)Arnalich et al. Critical Care 2010, 14:R47
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Age, years 60 (51 to 69) 61 (52 to 70) NS
Female 13 (44.8) 25 (43.3) NS
Hypertension 15(51.7) 33 (58.9) NS
Diabetes 12 (41.4) 30 (53.6) NS
Coronary artery disease 12 (41.4) 27 (48.2) NS
Chronic heart failure 9 (31.0) 18 (32.1) NS
Witnessed arrest 18 (62.1) 29 (51.8) NS
Bystander CPR 10 (16.9) 15 (26.8) NS
Total downtime, min 20 (15 to 29) 27 (22 to 35) NS
CGS < 6 on arrival at the ER 24 (82.7) 50 (89.2) NS
Ongoing CPR on arrival at the ER 7 (24.1) 14 (25.0) NS
Palpable pulse on arrival in the ER 23 (79.3) 48 (85.7) NS
Supraventricular rhythm in the ER 17 (58.6) 37 (66.1) NS
Asystole 11 (37.9) 34 (60.7) < 0.01
Defibrillation in the ER 15 (51.7) 25 (44.6) NS
Adrenaline in the ER 21 (72.4) 46 (82.1) NS
Cardiogenic shock 5 (17.2) 11 (19.6) NS
Confirmed AMI as final diagnosis 19 (65.5) 29 (51.8) < 0.05
APACHE II score 34 (32 to 38) 37 (33 to 41) NS
Plasma DNA (GE/ml) 2,400 (1,370 to 3,550) 4,150 (3,460 to 5,180) 0.001
Basal lactate (mmol/l) 10.8 (9.1 to 12.2) 11.5 (10.3 to 13.1) NS
6-h lactate (mmol/l) 5.5 (4.9 to 6.6) 6.9 (5.8 to 8.4) NS
6-h lactate clearance (%) 52 (47 to 65) 43 (27 to 59) NSArnalich et al. Critical Care 2010, 14:R47
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Third, some potential confounders like patient management 
at the emergency department and intensive care unit are dif-
ficult to control. In addition, some pre-analytical factors 
could have an impact on the results. To avoid contamination 
of the cell-free circulating plasma DNA measurements by 
residual white blood cells or platelets we used high-speed 
centrifugation at 16,000 g after storage, which almost com-
pletely eliminates cellular contamination in these assays. 
Opposing these limitations, the strengths of this study lie in 
the prospective design which includes a clearly defined 
patient sample, and the complete recording of premorbid, 
peri-arrest and immediate post-arrest variables. In addition, 
we measured lactate clearance as a marker of severity 
against which plasma DNA may be compared.
Conclusions
In conclusion, our study results indicate that plasma DNA 
measurement on arrival at the emergency room may help 
physicians to estimate outcome in patients with cardiac 
arrest outside the hospital. In fact, plasma DNA concentra-
tion was a strong independent predictor for 24-hour mortal-
ity and was also independently associated with hospital 
mortality. A large prospective multicenter study is war-
ranted to confirm the role of plasma DNA in outcome pre-
diction after cardiac arrest and to validate the optimal 
plasma DNA cutoff levels regarding early and late mortal-
ity.
Key messages
• The median plasma DNA concentration on arrival at 
the emergency department was two-fold higher in non-
survivors at 24 hours compared to those in survivors 
following cardiac arrest.
• Plasma DNA concentration was a strong independent 
predictor for 24-hour mortality and was also indepen-
dently associated with hospital mortality.
• Plasma DNA measurement on arrival at the emer-
gency room may help physicians to estimate outcome in 
patients with cardiac arrest outside the hospital.
Blood sugar (mg/dl) 195 (165 to 220) 230 (190 to 245) NS
Blood urea nitrogen (mg/dl) 34 (28 to 45) 40 (33 to 57) NS
Data are median (IQR) or number (%).
Table 3: Univariate analysis: comparisons of factors associated with in-hospital mortality (Continued)
Table 4: Multiple logistic regression analyses; independent predictors of 24-h and in-hospital mortality
24 -h mortality In-hospital mortality
Adjusted OR 95% CI P value Adjusted OR 95% CI P value
Plasma DNA (for each 
increase of 1 GE/ml)
1.001 1.001 to 1.002 < 0.001 1.001 1.001 to 1.002 < 0.001
Plasma DNA for each 
increase of 500 GE/ml)
1.756 1.314 to 2.347 < 0.001 1.359 1.125 to 2.350 < 0.01
6-h lactate (for each 
increase of 1 mmol/l)
1.348 0.912 to 1.631 NS 1.115 0.765 to 1.530 NS
Age (for each increase of 
one year)
1.031 0.899 to 1.041 NS 1.376 0.865 to 1.240 NS
Admission glucose (for 
each increase of 10 mg/dl)
1.019 0.833 to 1.282 NS 1.012 0.780 too 
1.320
NSArnalich et al. Critical Care 2010, 14:R47
http://ccforum.com/content/14/2/R47
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Figure 2 Receiver operating characteristics curve for six-hour se-
rum lactate concentrations and 24-hour and in-hospital mortali-
ty. The best cutoff value of six-hour lactate in predicting 24-hour 
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